4-((4-Ethyl-2,6-difluorophenyl)ethynyl)-4'-propyl-1,1'-biphenyl, 97%, 1g

Glycinamide Hydrochloride>98.0%(T)25g

(E)-ethyl 3-(2-chloro-4-(ethylamino)pyrimidin-5-yl)acrylate, 98%, 50mg

3-(3-FLUOROPHENYL)CYCLOBUTANONE, 95.0%, 250mg

DMT-2'-O-TBDMS-1-methylpseudouridine Phosphoramidite>95.0%(HPLC)(qNMR)50mg

3-aminobenzoic acid, >=98%, for synthesis, 50 g, plastic packaging.

3-Ethoxy-4-[(3-methyl-2-buten-1-yl)oxy]-benzaldehyde, 95.0%, 1g

3-Bromo-2-hydroxy-5-nitropyridine, 95.0%, 10g

(1,3-benzodioxol-5-ylmethyl)(3-methoxybenzyl)amine hydrobromide, 95.0%, 1g

4-chloro-2-(1-oxo-1,3,4,6,7,8,9,10-octahydro-2H-cyclohepta[4,5]pyrrolo[1,2-a]pyrazin-2-yl)nicotinaldehyde, 98%, 1g

3-isopropyl-3-methylpyrrolidine hydrochloride, 95.0%, 5g

Filtration unit with nylon membrane Pore size 0.2 μm, 150 ml, 150 ml, 50 mm, 12 Piece(s)

Boc-b-cyclohexyl-L-alanine methyl ester, 95.0%, 500g